Protocol summary

Study aim
Investigating the effectiveness of using digital health monitoring tools on improving physical health indicators and medication adherence in the elderly
Design
A randomized, single-blind, parallel-group, controlled clinical trial on 80 individuals over 60 years of age.
Settings and conduct
This randomized controlled trial enrolls adults ≥60 years attending six Tehran Oil Industry family health centers. Participants are selected through stratified random sampling proportional to each center’s share and gender balance, yielding 80 individuals. Assignment to the intervention (40) and control (40) groups uses stratified-block randomization by an independent statistician with allocation concealment via opaque numbered envelopes. Because the intervention—a digital package with a smartwatch and mobile app—cannot be blinded to participants, only the outcome assessor and statistical analyst are blinded. The 12-week intervention includes training, technical support, and adherence monitoring through weekly reports and motivational calls. Measurements are obtained at baseline and every two weeks using questionnaires, blood pressure/glucometer readings, and wearable-device data, and analyses employ appropriate statistical tests such as paired/independent t-tests, chi-square, and multivariate regression.
Participants/Inclusion and exclusion criteria
People aged 60 and over who visit family health centers and are literate or have a caregiver are included in this plan, and those who do not cooperate or have cognitive impairments are excluded.
Intervention groups
In the intervention group, people use a digital watch with a medication reminder app, a pedometer, and a heart rate monitor. The control group receives only usual care.
Main outcome variables
Fasting blood sugar; medication adherence; satisfaction with technology; use of devices, diastolic and systolic blood pressure.

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20251102067858N2
Registration date: 2025-12-09, 1404/09/18
Registration timing: prospective

Last update: 2025-12-09, 1404/09/18
Update count: 0
Registration date
2025-12-09, 1404/09/18
Registrant information
Name
Farhad Moradi Shahpar
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 8863 0228
Email address
f_moradishahpar@sbu.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2025-12-22, 1404/10/01
Expected recruitment end date
2026-02-20, 1404/12/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The Effectiveness of Using Digital Health and Physical Activity Monitoring Tools on Health Indicators and Treatment Adherence in Older Adults: A Randomized Controlled Study
Public title
The effectiveness of digital tools in improving the health of the elderly
Purpose
Supportive
Inclusion/Exclusion criteria
Inclusion criteria:
Elderly people over 60 years of age visiting family health centers Being literate or having a home caregiver
Exclusion criteria:
Non-cooperation Severe cognitive problems
Age
From 60 years old
Gender
Both
Phase
N/A
Groups that have been masked
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 80
Randomization (investigator's opinion)
Randomized
Randomization description
Sampling method Sampling of elderly people ≥60 years old is done by stratified random sampling from six family health centers of Tehran Oil Industry. Each center has a quota proportional to the population covered and gender distribution (50% female, 50% male) is maintained in the initial selection process. Random allocation method Eligible participants enter the study after written consent. The method of allocation of participants to groups is based on "stratified block randomization"; in this way, according to the combination of "health center × gender", twelve layers are formed and in each layer, variable blocks of 4 and 6 people are used to prevent predictability of the sequence. The allocation ratio in all layers is 1:1 so that in the end, each group consists of 40 people (20 women and 20 men) with complete gender balance. Random sequences are generated by an independent statistician using Random Allocation Software. To conceal the allocation, opaque, sealed, and numbered envelopes are used, and the researcher responsible for registration will be unaware of the allocation sequence until the envelope is opened.
Blinding (investigator's opinion)
Single blinded
Blinding description
Due to the nature of the intervention, blinding of participants is not possible, but the outcome assessor and statistical analyst will be blinded to the type of intervention. The master sequence file will be kept by an independent statistician, and a full description of the randomization method will be recorded and documented in an appendix to the protocol.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Tehran University of Medical Sceinces
Street address
6th floor, Headquarters of Tehran University of Medical Sceinces, Corner of Qods St. Kehsavarz Blvd
City
Tehran
Province
Tehran
Postal code
141765383761
Approval date
2025-07-13, 1404/04/22
Ethics committee reference number
IR.TUMS.NI.REC.1404.019

Health conditions studied

1

Description of health condition studied
Hypertension
ICD-10 code
I10
ICD-10 code description
Essential (primary) hypertension

2

Description of health condition studied
Diabetes
ICD-10 code
E08
ICD-10 code description
Diabetes mellitus due to underlying condition

Primary outcomes

1

Description
Using tools
Timepoint
At the beginning of the study and 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks and 12 weeks after the start of the intervention (use of the bracelet/smartwatch)
Method of measurement
Questionnaire (yes/no)

Secondary outcomes

1

Description
Fasting Blood Sugar
Timepoint
At the beginning of the study and 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks and 12 weeks after the start of the intervention (use of the bracelet/smartwatch)
Method of measurement
Glucometer

2

Description
Systolic and diastolic blood pressure
Timepoint
At the beginning of the study and 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks and 12 weeks after the start of the intervention (use of the bracelet/smartwatch)
Method of measurement
Digital blood pressure monitor

3

Description
Medication adherence
Timepoint
At the beginning of the study and 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks and 12 weeks after the start of the intervention (use of the bracelet/smartwatch)
Method of measurement
Score from the MMAS-8 questionnaire

4

Description
Satisfaction with technology
Timepoint
At the beginning of the study and 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks and 12 weeks after the start of the intervention (use of the bracelet/smartwatch)
Method of measurement
Average scores on the TAM (Technology Acceptance Model) questionnaire

Intervention groups

1

Description
The intervention includes a “digital elderly monitoring package” consisting of a TCHZ10 smartwatch capable of measuring steps, hourly activity, heart rate, and data transmission to a dedicated study app; the app is activated with a participant-specific user account, daily status dashboard, educational messages, and the ability to automatically send data to a secure research server. The intervention will be implemented for 12 weeks, and participants are required to use the device for at least 10 hours per day. At the beginning, a 30- to 45-minute in-person session will be held at the center for installation, instruction in use, and brochure presentation, and telephone support will be provided for technical issues and reporting of potential complications throughout the study. Adherence will be monitored by receiving weekly reports of usage hours and key indicators, and in the event of decreased adherence, motivational calls and troubleshooting guidance will be made. The control group will receive the center’s usual care without any digital tools. All device settings, app version, and educational instructions are fully documented in the protocol’s technical appendix, allowing for accurate replication of the intervention.
Category
Prevention

2

Description
Control group: The control group only receives the usual care provided in family health centers, namely examination, prescription of medication and diagnostic procedures, drug counseling, and specialist referral if necessary.
Category
Prevention

Recruitment centers

1

Recruitment center
Name of recruitment center
Tehran Oil Industry Family Health Centers
Full name of responsible person
Kourosh Hashemi Asl
Street address
No.27, Behafarin St. Karimkhan Ave, Valiasr Square
City
Tehran
Province
Tehran
Postal code
1415814687
Phone
+98 21 8889 2156
Fax
+98 21 8893 5711
Email
hashemiasl@yahoo.com
Web page address

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Dr. Ramin Kordi
Street address
6th floor, Headquarter of Tehran University of Medical Sceinces, Corner of Qods St. Keshavarz Blvd
City
Tehran
Province
Tehran
Postal code
141765383761
Phone
+98 21 8163 3698
Email
vcr@tums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Tehran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Farhad Moradi Shahpar
Position
Reseacher
Latest degree
Ph.D.
Other areas of specialty/work
Sport Medicine
Street address
Sports Medicine Research Center, No 7, Ahmadi Street, Jalal-e-Al-e-Ahmad Highway
City
Tehran
Province
Tehran
Postal code
141734143
Phone
+98 21 8863 0228
Fax
Email
f_moradishahpar@sbu.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Farhad Moradi Shahpar
Position
Reseacher
Latest degree
Ph.D.
Other areas of specialty/work
Sport Medicine
Street address
Sports Medicine Research Center, No 7, Ahmadi Street, Jalal-e-Al-e-Ahmad Highway
City
Tehran
Province
Tehran
Postal code
1411734143
Phone
+98 21 8863 0228
Fax
Email
f_moradishahpar@sbu.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Farhad Moradi Shahpar
Position
Reseacher
Latest degree
Ph.D.
Other areas of specialty/work
Sport Medicine
Street address
Sports Medicine Research Center, No 7, Ahmadi Street, Jalal-e-Al-e-Ahmad Highway
City
Tehran
Province
Tehran
Postal code
1411734143
Phone
+98 21 8863 0228
Fax
Email
f_moradishahpar@sbu.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Title and more details about the data/document
If requested by the researchers, after observing ethical and legal considerations, all data will be made available exclusively to the researcher in the form of an Excel or SPSS file in order to advance knowledge, without mentioning the names and characteristics of the subjects.
When the data will become available and for how long
Up to one year after publication of the article
To whom data/document is available
Reputable researchers at academic institutions
Under which criteria data/document could be used
For use in subsequent research, which must be approved by the research ethics committee of a university or an accredited scientific center. This request is subject to approval by the Research Council of the Sports Medicine Research Center. Therefore, the subsequent analysis of the data must be based on research ethics and contribute to the advancement of knowledge.
From where data/document is obtainable
The research manager Dr. Farhad Moradi Shahpar should be emailed. E-mail address: drfmoradi@yahoo.com
What processes are involved for a request to access data/document
After receiving the request from the Research Council of the Research Center, the research plan is prepared and, if approved, the desired information is made available to the researcher, in compliance with legal requirements.
Comments
Loading...